These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34218)
1. [Dietary and drug treatments of calcium nephrolithiasis (author's transl)]. Mirouze J; Monnier L; Granier MP; Borderies A; Gauthier N Sem Hop; 1979 Jan 8-15; 55(1-2):7-13. PubMed ID: 34218 [TBL] [Abstract][Full Text] [Related]
2. Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment. Hallson PC; Rose GA Br J Urol; 1976; 48(7):515-24. PubMed ID: 13904 [TBL] [Abstract][Full Text] [Related]
3. Medical management of nephrolithiasis. Pak CY J Urol; 1982 Dec; 128(6):1157-64. PubMed ID: 6759686 [No Abstract] [Full Text] [Related]
5. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides. Hering F; Lutzeyer W Eur Urol; 1979; 5(1):29-31. PubMed ID: 428408 [TBL] [Abstract][Full Text] [Related]
6. The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers. Pak CY; Nicar M; Northcutt C Contrib Nephrol; 1982; 33():136-51. PubMed ID: 6749417 [No Abstract] [Full Text] [Related]
7. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis. Cohanim M; Yendt ER Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033 [TBL] [Abstract][Full Text] [Related]
8. Calcium stone disease: an overview. Goldwasser B; Weinerth JL; Carson CC J Urol; 1986 Jan; 135(1):1-9. PubMed ID: 3510312 [No Abstract] [Full Text] [Related]
9. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288 [TBL] [Abstract][Full Text] [Related]
10. Is there a need for medical evaluation and treatment of nephrolithiasis in the "age of lithotripsy"? Preminger GM Semin Urol; 1994 Feb; 12(1):51-64. PubMed ID: 8197337 [No Abstract] [Full Text] [Related]
11. Physiological basis for absorptive and renal hypercalciurias. Pak CY Am J Physiol; 1979 Dec; 237(6):F415-23. PubMed ID: 229736 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides. Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B Scand J Urol Nephrol Suppl; 1980; 53():239-52. PubMed ID: 6938001 [No Abstract] [Full Text] [Related]
14. Is selective therapy of recurrent nephrolithiasis possible? Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of calcium nephrolithiasis with potassium citrate. Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044 [TBL] [Abstract][Full Text] [Related]
16. The causes and medical treatment of renal calculi. Rose GA Practitioner; 1977 Jan; 218(1303):74-80. PubMed ID: 13357 [No Abstract] [Full Text] [Related]
19. Pathophysiology of hypercalciuria. Coe FL; Bushinsky DA Am J Physiol; 1984 Jul; 247(1 Pt 2):F1-13. PubMed ID: 6377922 [TBL] [Abstract][Full Text] [Related]
20. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look]. Hess B Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]